# Keraplast Technologies, LLC: Form D filings

Keraplast Technologies, LLC, a biotechnology company in San Antonio, TX, filed 4 Form D notices with the SEC between 2009 and 2011. The latest, on February 9, 2011, reports an offering of $1.3 million with nothing sold yet.

Find out what Keraplast Technologies, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Keraplast%20Technologies%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Keraplast%20Technologies%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fkeraplast-technologies-llc-1466154)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Keraplast%20Technologies%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Keraplast%20Technologies%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fkeraplast-technologies-llc-1466154)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Texas](https://specstream.ai/data/form-d/state/texas): 4,800 rows, by operating companies, filed since November 1, 2024, $128, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/texas
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 19210 HUEBNER ROAD, SUITE 200, San Antonio, TX, 78258
- Phone: (210) 494-5596
- Industry: Biotechnology
- Entity type: Limited Liability Company
- Incorporated in: Texas
- Revenue range: $1,000,001 - $5,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1466154

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 9, 2011 | Amendment | $1,267,476 | $0 | $1,267,476 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1466154/000146615411000001/0001466154-11-000001-index.htm) |
| Dec 30, 2010 | New notice | $150,000 | $0 | $150,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1466154/000146615410000003/0001466154-10-000003-index.htm) |
| May 27, 2010 | New notice | $5,000,000 | $2,500,000 | $2,500,000 | 1 | May 20, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1466154/000146615410000002/0001466154-10-000002-index.htm) |
| Jun 19, 2009 | New notice | $2,500,000 | $2,371,149 | $128,851 | 14 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1466154/000146615409000001/0001466154-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Tim Herring | Director |  |
| Robert Smith | Director |  |
| Gregory Kozmetsky | Director |  |
| Charles LeMaistre | Director |  |
| Michael Espensen | Executive Officer, Director |  |
| Norman Blake | Director |  |
| William Shea | Director |  |

## Other biotechnology companies in Texas that filed recently

- [Nuclein, LLC](https://specstream.ai/data/form-d/company/nuclein-llc-1787352) $15.7 million · Oct 27, 2026
- [OncoNano Medicine, Inc.](https://specstream.ai/data/form-d/company/onconano-medicine-inc-1735726) $10.1 million · Oct 8, 2026
- [Solaris Endovascular Inc.](https://specstream.ai/data/form-d/company/solaris-endovascular-inc-2156481) $5 million · Oct 1, 2026
- [Hera Biotech, Inc.](https://specstream.ai/data/form-d/company/hera-biotech-inc-1831293) $1.7 million · Sep 23, 2026
- [Kayak Therapeutics, Inc.](https://specstream.ai/data/form-d/company/kayak-therapeutics-inc-2088831) $25 million · Aug 21, 2026
- [InnovoTEX Inc.](https://specstream.ai/data/form-d/company/innovotex-inc-1971887) $2.7 million · Aug 18, 2026

[Every Form D from the week of Feb 7, 2011](https://specstream.ai/data/form-d/week/2011-02-07) · [All recent filings in Texas](https://specstream.ai/data/form-d/state/texas) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Keraplast Technologies, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).